ASCO GU 2020 Penile, Urethral, Testicular, and Adrenal Cancers
Viewing 1-20 of 20 articles
ASCO GU 2020: Evaluation of the Oncologic Benefit of Adjunctive Surgery at Time of Post-Chemotherapy Retroperitoneal Lymph Node Dissection
ASCO GU 2020: Intravesical Irrigation to Prevent Early Bladder Recurrence in Patients Undergoing Laparoscopic Radical Nephroureterectomy for Upper Urinary Tract Cancer
ASCO GU 2020: Atezolizumab Therapy for Upper Tract Urothelial Carcinoma: Subgroup Analysis of the Single-Arm International SAUL Study in Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
ASCO GU 2020: Current Developments in Rare Urologic Malignancies: Are Biomarkers Going to Change the Future of Testicular Cancer?
ASCO GU 2020: SEMITEP: De-Escalating Chemotherapy in Low-Volume Metastatic Seminoma Based on Early FDG-PET
ASCO GU 2020: Prognostic Factors in Advanced Seminoma: An Analysis from the IGCCCG Update Consortium
ASCO GU 2020: Developments in Rare Urologic Malignancies: Are biomarkers going to change the future of testicular cancer?
ASCO GU 2020: Comprehensive Genomic Profiling (CGP) of Histologic Subtypes of Urethral Carcinomas (UrthCa)
ASCO GU 2020: Chemotherapy/Radiation-Sparing Management Strategies for Early-Stage Germ Cell Tumors - Urologists Perspective
ASCO GU 2020: Evaluation of the Oncologic Benefit of Adjunctive Surgery at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND)